
FDA warns on unapproved CBD products marketed for pain relief
Fox News
The Food and Drug Administration issued a warning to two companies selling over-the-counter products labeled as containing cannabidiol (CBD) without receiving the agency’s approval to do so.
In the letter sent to Honest Globe Inc., the FDA said the company is selling "ELIXICURE ORIGINAL PAIN RELIEF with CBD)" (roll-on and pump versions) and "ELIXCURE LAVENDER PAIN RELIEF with CBD" (roll-on and pump versions) which are "misbranded drugs" that cannot be legally marketed without an approved new drug application, regardless of whether the CBD is presented on the labeling as an active ingredient or an inactive ingredient. Biolyte Laboratories LLC was warned on it’ "(b)(4) Silver Gel," "(b)(4) Silver Gel with Aloe," "(b)(4) Silver Liquid Supplement," "(b)(4) Therapeutic Pain Gel," "(b)(4) Pain Relief Cream," and "(b)(4) Magnesium Oil Spray."More Related News